The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
3 CEOs Not Earning Their Keep
There's nothing worse than excessive CEO compensation with little to nothing to show for it. We look at three leaders who are simply paid way too much. More
S&P 500 Ends Q1 at All-Time Highs — Thursday’s IP Market Recap
The S&P 500 and the Dow Jones Industrial Average both finished the first quarter of 2013 by setting new all-time highs. More
5 Stocks With Great Earnings Surprises — LMCA MCBC IDCC WLB WGO
This week, these five stocks have the best ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader. More
5 Stocks With Poor Earnings Surprises — WPC CBB ROMA MOD NX
This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader. More
10 Worst “Strong Sell” Stocks This Week — HMY FDML PAY and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq rose 4.6%, the Dow is up 8.3%, and the S&P has risen 6.9%. More
